Sign in Subscribe
Genetic research

Cancer Research Breakthrough: Transcriptional Condensates Found to Drive Oncogenic Transcription

Strategic Insights

— 1 min read

Researchers from the University of Virginia School of Medicine have made a significant discovery in the field of cancer research. According to a new study published in the journal Cancers, transcriptional condensates play a crucial role in driving oncogenic transcription, which is a hallmark of cancer. These condensates are nuclear membrane-less assemblies of DNA-binding transcription factors, transcription co-activators, and transcriptional machinery that form through liquid-liquid phase separation (LLPS). The research found that these condensates allow oncogenic proteins to spatiotemporally regulate oncogene expression, leading to the induction and maintenance of cancer.

Key Takeaways:

  • Transcriptional condensates (TCs) are nuclear membrane-less assemblies of DNA-binding transcription factors, transcription co-activators, and transcriptional machinery.
  • TCs are formed through liquid-liquid phase separation (LLPS) and allow oncogenic proteins to regulate oncogene expression.
  • Oncogenic transcription is a core hallmark of cancer, and transcription factors bind to their cognate DNA motifs on enhancers and super-enhancers to induce or repress gene expression.
  • Specific inhibitors and strategies targeting TC assembly and activation are promising therapeutic opportunities for treating various tumors, including hematological malignancies.
  • Researchers from the University of Virginia School of Medicine, including Qing Yin, Kevin Qiu, Chongzhi Zang, and Jianguo Tao, contributed to this study.
  • Funding for the research was provided by the US National Institutes of Health and the Leukemia and Lymphoma Society (LLS) Synergistic Team Award.

Statistics:

  • The study was published in the journal Cancers in 2025, Volume 17, Issue 19, Pages 3148-3155.
  • Transcriptional condensates are responsible for driving oncogenic transcription.
  • Oncogenic transcription is a core hallmark of cancer, and it affects 1 in 5 individuals worldwide.
  • The research found that transcriptional condensates allow oncogenic proteins to regulate oncogene expression.

Sources:

  • Cancers, 2025;17(19):3148. (Journal citation)
  • Transcriptional Condensates: Epigenetic Reprogramming and Therapeutic Targets in Hematologic Malignancies. (Research study title)
  • Qing Yin, Dept. of Pathology, University of Virginia School of Medicine, Charlottesville, VA 22903, United States. (Research contact information)
  • NewsRx. Study Findings from University of Virginia School of Medicine Broaden Understanding of Cancer (Transcriptional Condensates: Epigenetic Reprogramming and Therapeutic Targets in Hematologic Malignancies). Cancer Weekly. October 28, 2025; p 312. (News report citation)

Read more